Emerging Biomarker Tests May Refine Early Autism Identification — With Important Limitations

Research into biological markers associated with autism is yielding new approaches that may eventually help refine early identification processes. These emerging methods — including metabolic analysis, eye-tracking measurements, and digital behavior assessment — aim to provide clinicians with additional, objective data points when evaluating children. However, experts stress these tools should complement rather replace comprehensive evaluations by specialists familiar with neurodiverse development.

Metabolic Markers Show Promise for Specific Subgroups

A 2026 study in Nature identified elevated urinary metabolites in a subgroup of autistic children with specific gut microbiome differences. This finding suggests potential for future tests targeting this biological subtype, though researchers emphasize it would not apply to all autistic individuals. Separately, CUHK researchers are piloting a stool-based test analyzing similar microbial markers, while commercial labs like MicroSigX and LinusBio have begun marketing related tests despite limited independent validation.

Eye-Tracking Offers Supplemental Data Research suggests eye-tracking patterns may provide useful supplemental information during evaluations.

Eye-Tracking Offers Supplemental Data

Research suggests eye-tracking patterns may provide useful supplemental information during evaluations. A 2026 Contemporary Pediatrics article describes how these tools measure visual attention differences but require careful interpretation alongside other clinical observations. As noted in Psychiatry Advisor, these methods show promise but cannot standalone diagnose autism and may be influenced by various neurological factors.

Digital Tools May Reduce Screening Errors

Digital phenotyping approaches, including analysis of home videos and electronic health records, aim to reduce identification errors. A 2025 Frontiers study found machine learning could help flag potential autism markers in toddler behavior, while Science Advances research demonstrated how algorithms accounting for co-occurring conditions might decrease false positives in screening.

Why Additional Markers Matter

Current identification methods rely heavily on behavioral observations and caregiver reports, which can vary across clinicians and cultural contexts. Additional biological markers might eventually help provide more consistent data — particularly for children whose behavioral presentations don't match traditional expectations. However, as emphasized in NIH research, these tools must be validated across diverse populations and integrated thoughtfully into existing neurodiversity-affirming practices.

Autistic self-advocates stress that any new identification methods should prioritize connecting individuals with appropriate supports rather than simply applying labels. The CAS Insights report notes the importance of ensuring biomarker research aligns with community needs and respects neurodiversity principles.